MSRB3 and cancer: These findings validated the predicted targets of miR-7641 in different cell lines and supported the possible involvement of miR-7641 in cancers, although the targeting efficiency could vary depending on the cell line; however, several genes, such as RPS16, RNF4, TNFSF10, EMC8, and MSRB3 were downregulated in most of the cell lines and PIGC remained unchanged in all cell lines.